C-IISchedule II Controlled Substance (USA)
References in periodicals archive ?
According to FDA and DEA, buprenorphine has a lower potential for abuse relative to C-II opioids such as oxycodone, oxymorphone, morphine and hydromorphone, the opioids in OxyContin, Opana ER, Embeda and Exalgo, respectively.
Given a choice, clinicians are more likely to use C-III pain relievers over C-II pain relievers, particularly for moderate to moderately severe pain.
From the above discussion we felt that the probable diagnosis of the child would be Familial Chylomicronemia / Hypertriglyceridemia which could be either due to LPL deficiency or Apo C-II deficiency.
Investors are cautioned that forward-looking statements involve risks and uncertainties which may affect the company's business and prospects, including the risks that the launch of oxycodone HCl controlled release tablets C-II in 10, 20, 40 and 80 mg strengths will be delayed; changing market conditions; the results of new or changed regulations regarding authorized generics; the impact of competitive products and pricing; and other risks and uncertainties based on economic, competitive, governmental, technological and other factors discussed in the Company's Annual Report on Form 10-K and its other filings with the Securities and Exchange Commission.
AaiPharma recently completed the acquisition of four C-II pain products and the launch and marketing promotion of these products are planned to begin in the first quarter of 2004.
Phillip Frost, the holder of BankUnited's Series C and Series C-II classes of preferred stock, has exercised its right to convert both classes to Class A Common Stock.
BankUnited also called all 222,223 outstanding shares of its Series C-II Non-Cumulative, Convertible Preferred Stock at $9 per share.
As the pioneering manufacturer of controlled-release oral morphine, MS Contin(R) C-II Tablets (see Note A), The Purdue Frederick Company knows the effectiveness of oral morphine, when dosed correctly, in relieving cancer pain.